Simon Hambidge
Concepts (336)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 47 | 2026 | 1444 | 3.450 |
Why?
| | Influenza Vaccines | 24 | 2026 | 541 | 2.870 |
Why?
| | Vaccines | 19 | 2025 | 389 | 2.580 |
Why?
| | Influenza, Human | 18 | 2026 | 634 | 2.070 |
Why?
| | Immunization | 8 | 2021 | 375 | 1.960 |
Why?
| | Immunization Programs | 10 | 2022 | 194 | 1.510 |
Why?
| | Pediatric Obesity | 10 | 2024 | 635 | 1.420 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 11 | 2026 | 94 | 1.240 |
Why?
| | Adverse Drug Reaction Reporting Systems | 10 | 2023 | 81 | 1.210 |
Why?
| | Vaccination Coverage | 6 | 2026 | 106 | 1.150 |
Why?
| | Infant | 56 | 2026 | 10093 | 1.050 |
Why?
| | Child Health Services | 5 | 2022 | 188 | 0.950 |
Why?
| | Measles-Mumps-Rubella Vaccine | 9 | 2021 | 48 | 0.950 |
Why?
| | Parents | 8 | 2021 | 1393 | 0.900 |
Why?
| | Child, Preschool | 49 | 2026 | 11888 | 0.850 |
Why?
| | Attitude to Health | 3 | 2017 | 419 | 0.840 |
Why?
| | Chickenpox Vaccine | 9 | 2021 | 75 | 0.830 |
Why?
| | Reminder Systems | 3 | 2026 | 148 | 0.810 |
Why?
| | Terminology as Topic | 2 | 2017 | 253 | 0.810 |
Why?
| | Cohort Studies | 38 | 2024 | 6045 | 0.730 |
Why?
| | Managed Care Programs | 5 | 2017 | 137 | 0.720 |
Why?
| | Female | 100 | 2026 | 79080 | 0.690 |
Why?
| | Counseling | 3 | 2017 | 403 | 0.680 |
Why?
| | United States | 49 | 2026 | 16041 | 0.670 |
Why?
| | Government Programs | 1 | 2021 | 27 | 0.670 |
Why?
| | Immunization Schedule | 5 | 2021 | 186 | 0.660 |
Why?
| | Whooping Cough | 6 | 2026 | 59 | 0.650 |
Why?
| | Colorado | 20 | 2026 | 4588 | 0.650 |
Why?
| | Pregnancy | 31 | 2026 | 7217 | 0.630 |
Why?
| | Adolescent | 50 | 2026 | 22451 | 0.630 |
Why?
| | Child | 52 | 2026 | 22638 | 0.630 |
Why?
| | Humans | 126 | 2026 | 145625 | 0.630 |
Why?
| | Information Storage and Retrieval | 3 | 2020 | 121 | 0.610 |
Why?
| | Vaccines, Combined | 5 | 2020 | 49 | 0.610 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1403 | 0.600 |
Why?
| | Abortion, Spontaneous | 4 | 2025 | 119 | 0.600 |
Why?
| | Language | 4 | 2017 | 313 | 0.550 |
Why?
| | Preventive Health Services | 2 | 2013 | 154 | 0.550 |
Why?
| | Population Surveillance | 9 | 2017 | 477 | 0.550 |
Why?
| | Male | 74 | 2026 | 73014 | 0.550 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2025 | 437 | 0.540 |
Why?
| | Pneumococcal Vaccines | 3 | 2022 | 130 | 0.540 |
Why?
| | Seizures, Febrile | 5 | 2017 | 23 | 0.540 |
Why?
| | Anemia, Sickle Cell | 2 | 2011 | 322 | 0.510 |
Why?
| | School Health Services | 4 | 2014 | 217 | 0.500 |
Why?
| | Wounds and Injuries | 4 | 2008 | 956 | 0.500 |
Why?
| | Urban Population | 5 | 2016 | 496 | 0.500 |
Why?
| | Vulnerable Populations | 2 | 2009 | 177 | 0.480 |
Why?
| | Young Adult | 32 | 2026 | 14240 | 0.470 |
Why?
| | Safety-net Providers | 4 | 2021 | 132 | 0.460 |
Why?
| | Dental Caries | 1 | 2017 | 173 | 0.450 |
Why?
| | Oral Health | 1 | 2017 | 139 | 0.440 |
Why?
| | Adult | 45 | 2026 | 40821 | 0.440 |
Why?
| | Retrospective Studies | 38 | 2026 | 17291 | 0.430 |
Why?
| | Chickenpox | 2 | 2020 | 83 | 0.430 |
Why?
| | Seizures | 3 | 2014 | 489 | 0.430 |
Why?
| | Incidence | 18 | 2024 | 2910 | 0.420 |
Why?
| | Body Mass Index | 6 | 2024 | 2446 | 0.420 |
Why?
| | Office Visits | 2 | 2007 | 93 | 0.410 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2014 | 9 | 0.410 |
Why?
| | Emergency Service, Hospital | 6 | 2014 | 2357 | 0.410 |
Why?
| | Infant, Newborn | 20 | 2026 | 6449 | 0.400 |
Why?
| | Case-Control Studies | 14 | 2025 | 3633 | 0.390 |
Why?
| | Product Surveillance, Postmarketing | 6 | 2022 | 74 | 0.390 |
Why?
| | Primary Health Care | 6 | 2021 | 1768 | 0.380 |
Why?
| | Self Report | 4 | 2026 | 869 | 0.380 |
Why?
| | Hospitalization | 6 | 2020 | 2468 | 0.380 |
Why?
| | Pertussis Vaccine | 2 | 2011 | 25 | 0.380 |
Why?
| | Bronchiolitis | 1 | 2014 | 87 | 0.380 |
Why?
| | Genes, MHC Class II | 1 | 2012 | 77 | 0.370 |
Why?
| | Electronic Health Records | 7 | 2026 | 1208 | 0.370 |
Why?
| | Papillomavirus Vaccines | 1 | 2016 | 296 | 0.370 |
Why?
| | Delivery of Health Care | 2 | 2017 | 942 | 0.360 |
Why?
| | Treatment Refusal | 2 | 2010 | 98 | 0.350 |
Why?
| | Weight Reduction Programs | 2 | 2024 | 140 | 0.350 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2014 | 189 | 0.350 |
Why?
| | Health Promotion | 2 | 2023 | 786 | 0.340 |
Why?
| | Rotavirus Vaccines | 3 | 2022 | 39 | 0.340 |
Why?
| | Health Services Research | 2 | 2012 | 389 | 0.340 |
Why?
| | Vaccines, Inactivated | 4 | 2012 | 70 | 0.320 |
Why?
| | Health Personnel | 1 | 2017 | 750 | 0.320 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 48 | 0.310 |
Why?
| | Meningococcal Vaccines | 3 | 2017 | 57 | 0.310 |
Why?
| | Communication Barriers | 1 | 2011 | 129 | 0.300 |
Why?
| | Immunization, Secondary | 3 | 2025 | 93 | 0.300 |
Why?
| | Middle Aged | 27 | 2026 | 36359 | 0.300 |
Why?
| | Risk Assessment | 12 | 2020 | 3678 | 0.300 |
Why?
| | Urban Health | 2 | 2006 | 95 | 0.290 |
Why?
| | Case Management | 1 | 2009 | 66 | 0.290 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2022 | 94 | 0.270 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 18 | 0.270 |
Why?
| | Congenital Abnormalities | 3 | 2017 | 108 | 0.260 |
Why?
| | Cross-Sectional Studies | 8 | 2026 | 5875 | 0.260 |
Why?
| | Anaphylaxis | 3 | 2021 | 105 | 0.260 |
Why?
| | Health Services Accessibility | 4 | 2011 | 1101 | 0.260 |
Why?
| | Insurance, Health | 3 | 2012 | 315 | 0.250 |
Why?
| | Pediatrics | 2 | 2006 | 1122 | 0.250 |
Why?
| | Measles | 2 | 2020 | 46 | 0.250 |
Why?
| | Internet | 1 | 2011 | 656 | 0.250 |
Why?
| | Child Care | 1 | 2007 | 32 | 0.250 |
Why?
| | Poverty | 5 | 2021 | 530 | 0.250 |
Why?
| | Community Health Services | 2 | 2010 | 229 | 0.240 |
Why?
| | Accident Prevention | 1 | 2006 | 25 | 0.240 |
Why?
| | Child Development | 1 | 2011 | 481 | 0.240 |
Why?
| | Risk | 9 | 2017 | 917 | 0.230 |
Why?
| | Herpes Zoster | 2 | 2020 | 318 | 0.230 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2017 | 28 | 0.230 |
Why?
| | Stillbirth | 2 | 2024 | 83 | 0.230 |
Why?
| | Chorioamnionitis | 2 | 2017 | 50 | 0.220 |
Why?
| | International Classification of Diseases | 2 | 2020 | 142 | 0.220 |
Why?
| | Aluminum | 2 | 2022 | 43 | 0.220 |
Why?
| | Developmental Disabilities | 2 | 2020 | 280 | 0.220 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2025 | 39 | 0.210 |
Why?
| | Narration | 1 | 2026 | 82 | 0.210 |
Why?
| | Mass Screening | 2 | 2015 | 1300 | 0.200 |
Why?
| | Prenatal Care | 2 | 2017 | 310 | 0.200 |
Why?
| | Athletic Injuries | 3 | 2006 | 574 | 0.200 |
Why?
| | Patient Acceptance of Health Care | 5 | 2024 | 880 | 0.200 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 139 | 0.200 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2014 | 97 | 0.190 |
Why?
| | Seasons | 6 | 2024 | 535 | 0.190 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 3 | 2022 | 266 | 0.190 |
Why?
| | Smallpox Vaccine | 1 | 2022 | 23 | 0.190 |
Why?
| | Multivariate Analysis | 4 | 2015 | 1531 | 0.180 |
Why?
| | Cataplexy | 1 | 2022 | 8 | 0.180 |
Why?
| | Bell Palsy | 1 | 2022 | 9 | 0.180 |
Why?
| | Narcolepsy | 1 | 2022 | 25 | 0.180 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2021 | 304 | 0.180 |
Why?
| | Eczema | 1 | 2022 | 66 | 0.180 |
Why?
| | Thrombocytopenia | 2 | 2022 | 205 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 104 | 0.170 |
Why?
| | Healthcare Disparities | 2 | 2021 | 728 | 0.170 |
Why?
| | Motivation | 2 | 2017 | 601 | 0.170 |
Why?
| | Disease Outbreaks | 1 | 2024 | 420 | 0.170 |
Why?
| | Pregnancy Outcome | 5 | 2025 | 502 | 0.170 |
Why?
| | Premature Birth | 4 | 2024 | 389 | 0.160 |
Why?
| | Fever | 2 | 2013 | 320 | 0.160 |
Why?
| | Risk Factors | 8 | 2020 | 10840 | 0.160 |
Why?
| | Pregnancy Complications | 3 | 2017 | 605 | 0.160 |
Why?
| | Databases, Factual | 4 | 2025 | 1481 | 0.160 |
Why?
| | Vaccination Refusal | 1 | 2021 | 61 | 0.160 |
Why?
| | Focus Groups | 2 | 2014 | 587 | 0.150 |
Why?
| | Mumps | 1 | 2020 | 21 | 0.150 |
Why?
| | Diphtheria-Tetanus Vaccine | 2 | 2009 | 5 | 0.150 |
Why?
| | Australia | 1 | 2020 | 291 | 0.150 |
Why?
| | Age Distribution | 4 | 2010 | 395 | 0.150 |
Why?
| | Sex Distribution | 4 | 2010 | 379 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 992 | 0.140 |
Why?
| | Tetanus Toxoid | 2 | 2015 | 34 | 0.140 |
Why?
| | Regression Analysis | 4 | 2015 | 994 | 0.140 |
Why?
| | Community Health Centers | 2 | 2009 | 59 | 0.130 |
Why?
| | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 13 | 0.130 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2017 | 26 | 0.130 |
Why?
| | Paint | 1 | 2017 | 8 | 0.130 |
Why?
| | Syncope | 1 | 2017 | 48 | 0.130 |
Why?
| | Diagnosis, Oral | 1 | 2017 | 8 | 0.130 |
Why?
| | Confidence Intervals | 3 | 2021 | 328 | 0.130 |
Why?
| | Dentists | 1 | 2017 | 21 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 1370 | 0.130 |
Why?
| | Aged | 8 | 2025 | 26251 | 0.130 |
Why?
| | Infant, Small for Gestational Age | 2 | 2015 | 118 | 0.130 |
Why?
| | Fluorides | 1 | 2017 | 50 | 0.130 |
Why?
| | Preconception Care | 1 | 2017 | 50 | 0.130 |
Why?
| | Age Factors | 5 | 2017 | 3321 | 0.120 |
Why?
| | Prevalence | 4 | 2020 | 2852 | 0.120 |
Why?
| | Logistic Models | 3 | 2015 | 2112 | 0.120 |
Why?
| | Caregivers | 1 | 2026 | 1079 | 0.120 |
Why?
| | Drug Hypersensitivity | 1 | 2017 | 93 | 0.120 |
Why?
| | Phosphates | 1 | 2017 | 175 | 0.120 |
Why?
| | Educational Status | 2 | 2023 | 466 | 0.110 |
Why?
| | Infant, Newborn, Diseases | 1 | 2017 | 113 | 0.110 |
Why?
| | Registries | 4 | 2010 | 2382 | 0.110 |
Why?
| | Time Factors | 9 | 2022 | 7079 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 379 | 0.110 |
Why?
| | Causality | 2 | 2006 | 128 | 0.110 |
Why?
| | Sex Factors | 2 | 2021 | 2101 | 0.110 |
Why?
| | Health Care Surveys | 2 | 2007 | 538 | 0.110 |
Why?
| | Telemedicine | 1 | 2024 | 956 | 0.100 |
Why?
| | Parental Consent | 1 | 2014 | 25 | 0.100 |
Why?
| | Fruit | 1 | 2015 | 144 | 0.100 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2014 | 27 | 0.100 |
Why?
| | Computer Simulation | 3 | 2013 | 1014 | 0.100 |
Why?
| | Vegetables | 1 | 2015 | 159 | 0.100 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2014 | 69 | 0.100 |
Why?
| | Pandemics | 4 | 2024 | 1700 | 0.100 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 63 | 0.100 |
Why?
| | Reimbursement Mechanisms | 1 | 2014 | 78 | 0.100 |
Why?
| | Predictive Value of Tests | 3 | 2009 | 2097 | 0.100 |
Why?
| | Social Environment | 1 | 2015 | 246 | 0.100 |
Why?
| | Papillomavirus Infections | 1 | 2017 | 345 | 0.100 |
Why?
| | Comprehension | 1 | 2014 | 175 | 0.090 |
Why?
| | Patient Navigation | 1 | 2015 | 126 | 0.090 |
Why?
| | Drug Eruptions | 1 | 2013 | 28 | 0.090 |
Why?
| | Rotavirus Infections | 2 | 2012 | 34 | 0.090 |
Why?
| | Infant, Premature, Diseases | 1 | 2014 | 113 | 0.090 |
Why?
| | Health Policy | 1 | 2016 | 399 | 0.090 |
Why?
| | Viral Vaccines | 1 | 2014 | 107 | 0.090 |
Why?
| | Utilization Review | 2 | 2009 | 37 | 0.090 |
Why?
| | Maternal Age | 2 | 2023 | 129 | 0.090 |
Why?
| | Models, Theoretical | 2 | 2013 | 558 | 0.090 |
Why?
| | Health Services | 1 | 2013 | 112 | 0.090 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5397 | 0.090 |
Why?
| | Intussusception | 1 | 2012 | 24 | 0.090 |
Why?
| | Respiratory Tract Infections | 2 | 2026 | 399 | 0.090 |
Why?
| | Health Education | 1 | 2015 | 346 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1323 | 0.090 |
Why?
| | Parenting | 1 | 2015 | 309 | 0.080 |
Why?
| | Electronic Mail | 1 | 2011 | 63 | 0.080 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 14 | 0.080 |
Why?
| | Database Management Systems | 1 | 2011 | 50 | 0.080 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 220 | 0.080 |
Why?
| | Asthma | 1 | 2022 | 1800 | 0.080 |
Why?
| | Health Care Costs | 1 | 2014 | 418 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 662 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2014 | 3005 | 0.080 |
Why?
| | Hepatitis A Vaccines | 1 | 2009 | 19 | 0.070 |
Why?
| | Diphtheria Toxoid | 1 | 2009 | 13 | 0.070 |
Why?
| | Altitude | 1 | 2014 | 469 | 0.070 |
Why?
| | Qualitative Research | 1 | 2017 | 1720 | 0.070 |
Why?
| | Hepatitis B Vaccines | 1 | 2009 | 43 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 6050 | 0.070 |
Why?
| | Models, Statistical | 1 | 2013 | 667 | 0.070 |
Why?
| | Drug Evaluation | 1 | 2008 | 78 | 0.070 |
Why?
| | Acetaminophen | 1 | 2011 | 268 | 0.070 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2008 | 5 | 0.070 |
Why?
| | Gastroenteritis | 1 | 2009 | 63 | 0.070 |
Why?
| | Medicaid | 2 | 2009 | 472 | 0.070 |
Why?
| | Patient Readmission | 1 | 2014 | 771 | 0.070 |
Why?
| | Platelet Count | 1 | 2008 | 94 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 253 | 0.070 |
Why?
| | Splenectomy | 1 | 2008 | 61 | 0.070 |
Why?
| | Acute Disease | 2 | 2008 | 1033 | 0.070 |
Why?
| | Probability | 1 | 2008 | 308 | 0.070 |
Why?
| | Communicable Disease Control | 1 | 2008 | 88 | 0.060 |
Why?
| | Ambulatory Care Facilities | 2 | 2009 | 267 | 0.060 |
Why?
| | Vaccines, Conjugate | 2 | 2022 | 60 | 0.060 |
Why?
| | House Calls | 1 | 2009 | 154 | 0.060 |
Why?
| | Health Surveys | 1 | 2009 | 511 | 0.060 |
Why?
| | Tetanus | 1 | 2026 | 29 | 0.060 |
Why?
| | Social Class | 1 | 2008 | 260 | 0.060 |
Why?
| | Domestic Violence | 1 | 2006 | 50 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2008 | 413 | 0.060 |
Why?
| | Chronic Disease | 2 | 2013 | 1824 | 0.060 |
Why?
| | Cluster Analysis | 2 | 2006 | 494 | 0.060 |
Why?
| | Skin | 1 | 2011 | 701 | 0.060 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2910 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2026 | 116 | 0.060 |
Why?
| | Patient Dropouts | 1 | 2006 | 65 | 0.060 |
Why?
| | Linear Models | 1 | 2008 | 847 | 0.060 |
Why?
| | Medication Adherence | 1 | 2009 | 535 | 0.050 |
Why?
| | Analysis of Variance | 1 | 2008 | 1293 | 0.050 |
Why?
| | Brain Ischemia | 1 | 2009 | 362 | 0.050 |
Why?
| | Disease Progression | 2 | 2014 | 2857 | 0.050 |
Why?
| | Research Design | 2 | 2013 | 1139 | 0.050 |
Why?
| | Pregnancy Trimester, First | 2 | 2017 | 139 | 0.050 |
Why?
| | Accidents, Home | 1 | 2004 | 32 | 0.050 |
Why?
| | Survival Analysis | 1 | 2008 | 1372 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 3930 | 0.050 |
Why?
| | Vaccines, Attenuated | 2 | 2017 | 129 | 0.050 |
Why?
| | Hospitals, General | 1 | 2024 | 23 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1212 | 0.050 |
Why?
| | Prospective Studies | 4 | 2021 | 8087 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2455 | 0.050 |
Why?
| | Physicians | 1 | 2012 | 954 | 0.050 |
Why?
| | Physicians, Family | 1 | 2005 | 179 | 0.050 |
Why?
| | Public Health Informatics | 1 | 2003 | 10 | 0.050 |
Why?
| | Ambulatory Care | 2 | 2013 | 627 | 0.050 |
Why?
| | Physician's Role | 1 | 2005 | 222 | 0.050 |
Why?
| | Accidents, Traffic | 1 | 2004 | 192 | 0.050 |
Why?
| | Health Status | 1 | 2008 | 822 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2015 | 8351 | 0.050 |
Why?
| | Family Practice | 1 | 2007 | 422 | 0.050 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1318 | 0.050 |
Why?
| | Benchmarking | 1 | 2024 | 192 | 0.050 |
Why?
| | Thigh | 2 | 2013 | 48 | 0.040 |
Why?
| | Odds Ratio | 2 | 2015 | 1070 | 0.040 |
Why?
| | Injections, Intramuscular | 2 | 2013 | 140 | 0.040 |
Why?
| | Arm | 2 | 2013 | 110 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2021 | 84 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 138 | 0.040 |
Why?
| | Algorithms | 2 | 2020 | 1843 | 0.040 |
Why?
| | Myocarditis | 1 | 2021 | 102 | 0.040 |
Why?
| | Systole | 1 | 2020 | 179 | 0.040 |
Why?
| | Pilot Projects | 1 | 2026 | 1878 | 0.040 |
Why?
| | Antigens | 1 | 2021 | 350 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 365 | 0.040 |
Why?
| | Poisson Distribution | 2 | 2011 | 77 | 0.040 |
Why?
| | Health Facilities | 1 | 2020 | 85 | 0.040 |
Why?
| | Stroke | 1 | 2009 | 1283 | 0.040 |
Why?
| | Mass Vaccination | 1 | 2019 | 18 | 0.040 |
Why?
| | Bias | 2 | 2013 | 196 | 0.040 |
Why?
| | Prognosis | 1 | 2008 | 4331 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 1581 | 0.030 |
Why?
| | Birth Weight | 1 | 2021 | 521 | 0.030 |
Why?
| | Health Behavior | 2 | 2015 | 801 | 0.030 |
Why?
| | Gestational Age | 1 | 2021 | 989 | 0.030 |
Why?
| | Exercise | 2 | 2020 | 2206 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2020 | 683 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 370 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2015 | 26 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2783 | 0.030 |
Why?
| | Computers | 1 | 2015 | 65 | 0.030 |
Why?
| | Video Games | 1 | 2015 | 25 | 0.030 |
Why?
| | Demography | 1 | 2015 | 274 | 0.030 |
Why?
| | Television | 1 | 2015 | 70 | 0.030 |
Why?
| | Refugees | 1 | 2015 | 83 | 0.030 |
Why?
| | Vasculitis | 1 | 2014 | 69 | 0.030 |
Why?
| | Contraindications | 1 | 2014 | 88 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1761 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2020 | 878 | 0.020 |
Why?
| | Family Characteristics | 1 | 2015 | 202 | 0.020 |
Why?
| | California | 1 | 2014 | 473 | 0.020 |
Why?
| | Emigrants and Immigrants | 1 | 2015 | 160 | 0.020 |
Why?
| | Drug Utilization | 1 | 2013 | 170 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2015 | 266 | 0.020 |
Why?
| | Monitoring, Immunologic | 1 | 2011 | 25 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 190 | 0.020 |
Why?
| | Sample Size | 1 | 2011 | 123 | 0.020 |
Why?
| | Schools | 1 | 2014 | 436 | 0.020 |
Why?
| | Family | 1 | 2015 | 680 | 0.020 |
Why?
| | Overweight | 1 | 2015 | 613 | 0.020 |
Why?
| | Data Collection | 1 | 2013 | 647 | 0.020 |
Why?
| | Safety Management | 1 | 2011 | 130 | 0.020 |
Why?
| | Safety | 1 | 2011 | 346 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 91 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 1074 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 782 | 0.020 |
Why?
| | Diet | 1 | 2015 | 1271 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2018 | 0.010 |
Why?
| | Health Care Reform | 1 | 2005 | 109 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1992 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 2005 | 283 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2006 | 1754 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3396 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2009 | 11744 | 0.010 |
Why?
|
|
Hambidge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|